You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Busulfan

Showing 1 - 25 of 765
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Busulfan Sample Collection Study

Not yet recruiting
  • Subjects Treated With Busulfan
  • MyCare Oncology Busulfan Assay Kit
  • (no location specified)
Jan 25, 2023

Myeloid Malignancies Trial in Chendu (fractionated busulfan-based conditioning regimen)

Recruiting
  • Myeloid Malignancies
  • fractionated busulfan-based conditioning regimen
  • Chendu, Sichuan, China
    West China Hospital, Sichuan University
Mar 29, 2023

Acute Myeloid Leukemia, MDS Trial in China (Fludarabine, busulfan and melphalan, Fludarabine and Busulfan)

Active, not recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • Fludarabine, busulfan and melphalan
  • Fludarabine and Busulfan
  • Fuzhou, Fujian, China
  • +8 more
Aug 14, 2023

Blood Samples to Identify Biomarkers of Busulfan

Active, not recruiting
  • Leukemia
  • +4 more
    • Seattle, Washington
      University of Washington
    Jan 4, 2023

    Myeloid Malignancies, Acute Myelogenous Leukemia, Chronic Myelogenous Leukemia Trial in Hackensack (Fludarabine and Busulfan

    Active, not recruiting
    • Myeloid Malignancies
    • +4 more
    • Fludarabine and Busulfan plus/minus Total Body Irradiation (low dose)
    • Fludarabine and Busulfan + Low Dose Total Body Irradiation (LD TBI)
    • Hackensack, New Jersey
      John Theurer Cancer Center at Hackensack University Medical Cent
    Feb 25, 2022

    Leukemia, Acute Lymphoblastic, Myeloid Leukemia, Acute, Biphenotypic Acute Leukemia Trial in Saint Petersburg (Fludarabine,

    Recruiting
    • Leukemia, Acute Lymphoblastic
    • +5 more
    • Saint Petersburg, Russian Federation
      RM Gorbacheva Research Institute
    Jul 19, 2022

    Cancer Trial in Jinan (Busulfan, Paclitaxel, Afatinib, Ceritinib, Crizotinib (Antineoplastic drugs))

    Recruiting
    • Cancer
    • Busulfan, Paclitaxel, Afatinib, Ceritinib, Crizotinib (Antineoplastic drugs)
    • Jinan, Shandong, China
      Shandong Provincial Qianfoshan Hospital
    Jul 18, 2022

    Severe Combined Immune Deficiency (SCID) Trial run by the National Institute of Allergy and Infectious Diseases (NIAID)

    Enrolling by invitation
    • Severe Combined Immune Deficiency (SCID)
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Aug 24, 2022

    Chronic Granulomatous Disease Trial run by the NIAID (Sirolimus, Cyclophosphamide, Alemtuzumab)

    Recruiting
    • Chronic Granulomatous Disease
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jul 23, 2022

    Acute Myeloid Leukemia, Pediatric Cancer Trial in Boston (Uproleselan, Fludarabine, Clofarabine)

    Recruiting
    • Acute Myeloid Leukemia
    • Pediatric Cancer
    • Boston, Massachusetts
    • +1 more
    Oct 24, 2022

    Acute Myeloid Leukemia, Adult, Myelodysplastic Syndrome(MDS), Allogeneic Hematopoietic Stem Cell Transplantation Trial in Wuhan

    Recruiting
    • Acute Myeloid Leukemia, Adult
    • +2 more
    • Fludarabine and Busulfan
    • Fludarabine and Melphalan
    • Wuhan, Hubei, China
      Wuhan Union Hospital, Tongji Medical college, Huazhong Universit
    Jan 5, 2023

    Hematologic Malignancies Trial in New York (Busulfan 3.2 mg/kg/day, Fludarabine, Melphalan)

    Recruiting
    • Hematologic Malignancies
    • Busulfan 3.2 mg/kg/day
    • +5 more
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Mar 14, 2022

    Hematopoietic Stem Cell Transplantation, Malignant Hematological Diseases Trial in Suzhou (Umbilical Cord Blood Transplantation)

    Recruiting
    • Hematopoietic Stem Cell Transplantation
    • Malignant Hematological Diseases
    • Umbilical Cord Blood Transplantation
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow university
    Jul 3, 2023

    Acute Leukemia Trial in Suzhou (mitoxantrone liposome, ATG)

    Recruiting
    • Acute Leukemia
    • mitoxantrone liposome
    • ATG
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow University
    Feb 13, 2023

    Intravenous Busulfan And Fludarabine Myeloablative Conditioning

    Completed
    • Acute Myeloid Leukemia
    • +3 more
      • (no location specified)
      Mar 16, 2022

      Cytarabine+Thiotepa + Fludarabine + Busulfan, T Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma Trial in Hangzhou

      Recruiting
      • Cytarabine+Thiotepa + Fludarabine + Busulfan
      • T Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma
      • cytarabine+thiotepa+ fludarabine + busulfan
      • Hangzhou, China
        The First Affiliated Hospital, College of Medicine, Zhejiang Uni
      Oct 26, 2022

      T-cell Non-Hodgkin Lymphoma, Lymphoma, Extranodal NK-T-Cell Trial in Busan, Daegu (Busulfan, Fludarabine)

      Recruiting
      • T-cell Non-Hodgkin Lymphoma
      • Lymphoma, Extranodal NK-T-Cell
      • Busan, Korea, Republic of
      • +1 more
      Aug 17, 2022

      T-cell Non-Hodgkin Lymphoma Trial in Boston (Cyclophosphamide, Doxorubicin, Vincristine)

      Terminated
      Has Results
      • T-cell Non-Hodgkin Lymphoma
      • Boston, Massachusetts
      • +1 more
      Jan 26, 2023

      Leukemia Trial (biological, drug, procedure, radiation)

      Active, not recruiting
      • Leukemia
      • aldesleukin
      • +9 more
      • (no location specified)
      Feb 17, 2022

      Severe Aplastic Anemia Trial (Busulfan, Flu/Cy/ATG or Cy/ATG)

      Not yet recruiting
      • Severe Aplastic Anemia
      • Busulfan
      • Flu/Cy/ATG or Cy/ATG
      • (no location specified)
      Oct 1, 2023

      Leukemia, MDS Trial (drug, procedure, radiation)

      Active, not recruiting
      • Leukemia
      • Myelodysplastic Syndromes
      • busulfan
      • +7 more
      • (no location specified)
      Feb 17, 2022

      Hematopoietic Malignancy, Relapse/Recurrence, Hematopoietic Stem Cell Transplantation Trial in Suzhou (Umbilical Cord Blood

      Recruiting
      • Hematopoietic Malignancy
      • +2 more
      • Umbilical Cord Blood Transplantation
      • Suzhou, Jiangsu, China
        The First Affiliated Hospital of Soochow university
      Nov 6, 2023

      Haploidentical Stem Cell Transplantation, Conditioning Trial in Xi'an (MA-BUCY2, BUCY2)

      Not yet recruiting
      • Haploidentical Stem Cell Transplantation
      • Conditioning
      • Xi'an, Shaanxi, China
        First Affiliated Hospital of Xian Jiaotong University
      Apr 14, 2023

      Lymphoproliferative Disorders, Autoimmune Lymphoproliferative, Immune System Diseases Trial run by the NCI (drug, radiation,

      Recruiting
      • Lymphoproliferative Disorders
      • +4 more
      • Busulfan test dose
      • +8 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 23, 2023

      Disorder Related to Bone Marrow Transplantation, Leukemia, Transplantation Infection Trial in Houston (Fludarabine, Clofarabine,

      Completed
      Has Results
      • Disorder Related to Bone Marrow Transplantation
      • +2 more
      • Houston, Texas
        University of Texas MD Anderson Cancer Center
      Nov 18, 2021